Jon S. Saxe

Insider Reports History

Entity
Individual
Location
First Horizon Pharmaceutical Corp, 660 Hembree Pkwy Ste 106, Roswell, GA
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jon S. Saxe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vistagen Therapeutics, Inc. Director Stock Option (Right to Buy) 14.1K Sep 6, 2024 Direct

Insider Reports Filed by Jon S. Saxe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VTGN Vistagen Therapeutics, Inc. Sep 6, 2024 1 $0 4 Sep 10, 2024 Director
VTGN Vistagen Therapeutics, Inc. Mar 4, 2024 1 $0 4 Mar 6, 2024 Director
VTGN VistaGen Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 3, 2022 Director